Cargando…
Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine–based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage
PURPOSE: Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown. The aim of the actual a...
Autores principales: | Steiger, Hans-Jakob, Ensner, Rolf, Andereggen, Lukas, Remonda, Luca, Berberat, Jatta, Marbacher, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913475/ https://www.ncbi.nlm.nih.gov/pubmed/35138488 http://dx.doi.org/10.1007/s00701-022-05145-6 |
Ejemplares similares
-
What is the Real Message of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial for Academic and Practising Cardiologists?
por: Mavromatis, Kreton, et al.
Publicado: (2020) -
Brain retraction injury after elective aneurysm clipping: a retrospective single-center cohort study
por: Konya, B., et al.
Publicado: (2022) -
Retrograde endovascular revascularization for chronic total occlusion of the internal carotid artery: a case report
por: Uno, Takeshi, et al.
Publicado: (2021) -
The ISCHEMIA Trial: And the Winner Is… the Patient
por: Avanzas, Pablo, et al.
Publicado: (2021) -
Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
por: Yap, Jonathan, et al.
Publicado: (2021)